Addition of an Author
Ryan L. Boudreau was erroneously not included as an author in the original publication [1]. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Detailed Contributions
Methodology: Dr. Boudreau designed and generated the mi-cAbl constructs to create a robust model for c-Abl knockdown through gene silencing.
Investigation: Dr. Boudreau cloned and screened a panel of four mi-cAbl vectors to determine which was best for knockdown (qRT-PCR and Western blots resulting in effective gene silencing as demonstrated throughout the manuscript).
Resources: mi-cAbl vectors served as a crucial custom resource made for and enabling these studies.
Writing—Review and Editing: Dr. Boudreau reviewed the manuscript and made recommendations for citing the appropriate literature on artificial miR designs.
Conceptualization, J.C.G.-G. and M.V.-M.; methodology, M.E.-F., D.T.-H., Y.M.-B., R.L.B. and J.C.G.-G.; software, M.E.-F. and D.T.-H.; formal analysis, M.E.-F. and D.T.-H.; writing—original draft preparation, M.E.-F., J.C.G.-G. and M.V.-M.; writing—review and editing, M.E.-F., R.L.B., J.C.G.-G. and M.V.-M.; visualization, M.E.-F., D.T.-H., J.C.G.-G. and M.V.-M.; supervision, J.C.G.-G. and M.V.-M.; project administration, Y.M.-B.; funding acquisition, J.C.G.-G. and M.V.-M. All authors have read and agreed to the published version of the manuscript.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
1. Escudero-Florez, M.; Torres-Hoyos, D.; Miranda-Brand, Y.; Boudreau, R.L.; Gallego-Gomez, J.C.; Vicente-Manzanares, M. Dengue Virus Infection Alters Inter-Endothelial Junctions and Promotes Endothelial-Mesenchymal-Transition-Like Changes in Human Microvascular Endothelial Cells. Viruses; 2023; 15, 1437. [DOI: https://dx.doi.org/10.3390/v15071437] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37515125]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details




1 Molecular and Translation Medicine Group, University of Antioquia, Medellin 050010, Colombia;
2 Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA;
3 Molecular Mechanisms Program, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, 37007 Salamanca, Spain